Induction and add-on therapy with Mitoxantrone and Interferon beta in multiple sclerosis

Neurological Sciences

Volumn 29, Issue SUPPL. 2, 2008, Pages

  Zaffaroni, Mauro ^a   Rizzo, Annalisa ^b   Baldini, Silvana Maria ^a   Ghezzi, Angelo ^a   Comi, Giancarlo ^a,b  

^a Centro Studi Sclerosi Multipla   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Combination therapy; Glatiramer acetate; Induction therapy; Interferon beta; Mitoxantrone; Rescue therapy

Indexed keywords

BETA INTERFERON; CYCLOPHOSPHAMIDE; GLATIRAMER; METHYLPREDNISOLONE; MITOXANTRONE; NATALIZUMAB;

ADD ON THERAPY; ADULT; AMENORRHEA; ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LYMPHOCYTOPENIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAPSE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; DISABILITY EVALUATION; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-BETA; MALE; MIDDLE AGED; MITOXANTRONE; MULTIPLE SCLEROSIS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 53649090647     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-008-0946-x     Document Type: Article

References (10)

1. Freedman MS, Patry DG, Grand'Maison F et al (2004) Treatment optimization in multiple sclerosis. Can J Neurol Sci 31:157-168
2. Stuart WH, Vermersch P (2004) Concomitant therapy in multiple sclerosis. Neurology 63:S28-S34
3. Fernandez O (2007) Combination therapy in multiple sclerosis. J Neurol Sci 259:95-103
4. Jeffery DR (2004) Use of combination therapy with immunomodulators and immunosuppressants in treating multiple sclerosis Neurology 63[Suppl 6]:S41-S46
5. Correale JT, Rush C, Amengua A, Goicochea MT (2005) Mitoxantrone as rescue therapy in worsening relapsing-remitting MS patients receiving IFN-β. J Neuroimmunol 162:173-183
6. Jeffery DR, Chepuri N, Durden D, Burdette J (2005) A pilot trial of combination therapy with mitoxantrone and interferon beta-1b using monthly gadolinium-enhanced magnetic resonance imaging. Multiple Sclerosis 11:296-301
7. Ramtahal J, Jacob A, Kumar D, Boggild M (2006) Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis J Neurol 253:1160-1164
8. Edan G, Comi G, Lebrun C et al (2007) The French-Italian Mitoxantrone-Interferon-beta Trial: A 3-year randomised study. Multiple Sclerosis 13[Suppl 2]:S22
9. Boster A, Edan G, Frohman E et al (2008) Intense immunosuppression in patients with rapidly worsening multiple sclerosis: Treatment guidelines for the clinician. Lancet 7:173-183
10. Debouverie M, Taillandier L, Pittion-Vouyovitch S et al (2007) Clinical follow-up of 304 patients with multiple sclerosis after three years mitoxantrone treatment. Mult Scler 13:626-631